NCT01008592View on ClinicalTrials.gov

The Effect of Levocetirizine on Inflammatory Mediators in Dermatographism

TerminatedOBSERVATIONAL
Enrollment

11

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

August 31, 2010

Study Completion Date

September 30, 2010

Conditions
RhinitisUrticaria
Interventions
DRUG

levocetirizine or placebo

oral administration, single tablet, 5 mg.

Trial Locations (1)

27157

Wake Forest University Health Sciences, Department of Dermatology, Winston-Salem

Sponsors

Collaborators (1)

UCB Pharma
All Listed Sponsors
collaborator

UCB Pharma

INDUSTRY

lead

Wake Forest University

OTHER

NCT01008592 - The Effect of Levocetirizine on Inflammatory Mediators in Dermatographism | Biotech Hunter | Biotech Hunter